nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—osteoarthritis—Prednisone—systemic scleroderma	0.67	1	CpDpCtD
Nabumetone—CYP1A2—Pentoxifylline—systemic scleroderma	0.0433	0.512	CbGbCtD
Nabumetone—CYP1A2—Leflunomide—systemic scleroderma	0.0413	0.488	CbGbCtD
Nabumetone—PTGS2—skeletal joint—systemic scleroderma	0.0052	0.114	CbGeAlD
Nabumetone—MPO—artery—systemic scleroderma	0.0048	0.105	CbGeAlD
Nabumetone—MPO—endothelium—systemic scleroderma	0.00405	0.0888	CbGeAlD
Nabumetone—MPO—blood vessel—systemic scleroderma	0.00374	0.0819	CbGeAlD
Nabumetone—PTGS1—artery—systemic scleroderma	0.00228	0.0499	CbGeAlD
Nabumetone—PTGS2—artery—systemic scleroderma	0.00218	0.0477	CbGeAlD
Nabumetone—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00193	0.624	CbGdCrCtD
Nabumetone—PTGS1—endothelium—systemic scleroderma	0.00192	0.0421	CbGeAlD
Nabumetone—MPO—connective tissue—systemic scleroderma	0.00192	0.042	CbGeAlD
Nabumetone—PTGS2—endothelium—systemic scleroderma	0.00184	0.0403	CbGeAlD
Nabumetone—PTGS1—blood vessel—systemic scleroderma	0.00177	0.0389	CbGeAlD
Nabumetone—MPO—skin of body—systemic scleroderma	0.00173	0.0379	CbGeAlD
Nabumetone—PTGS2—blood vessel—systemic scleroderma	0.0017	0.0371	CbGeAlD
Nabumetone—MPO—digestive system—systemic scleroderma	0.00138	0.0303	CbGeAlD
Nabumetone—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00116	0.376	CbGdCrCtD
Nabumetone—MPO—lung—systemic scleroderma	0.00116	0.0253	CbGeAlD
Nabumetone—PTGS1—connective tissue—systemic scleroderma	0.00091	0.0199	CbGeAlD
Nabumetone—PTGS2—connective tissue—systemic scleroderma	0.000869	0.019	CbGeAlD
Nabumetone—PTGS1—smooth muscle tissue—systemic scleroderma	0.000832	0.0182	CbGeAlD
Nabumetone—PTGS1—skin of body—systemic scleroderma	0.000821	0.018	CbGeAlD
Nabumetone—PTGS2—smooth muscle tissue—systemic scleroderma	0.000795	0.0174	CbGeAlD
Nabumetone—PTGS2—skin of body—systemic scleroderma	0.000785	0.0172	CbGeAlD
Nabumetone—CYP1A2—digestive system—systemic scleroderma	0.000758	0.0166	CbGeAlD
Nabumetone—PTGS1—digestive system—systemic scleroderma	0.000657	0.0144	CbGeAlD
Nabumetone—CYP1A2—lung—systemic scleroderma	0.000633	0.0139	CbGeAlD
Nabumetone—PTGS2—digestive system—systemic scleroderma	0.000628	0.0138	CbGeAlD
Nabumetone—PTGS1—tendon—systemic scleroderma	0.000625	0.0137	CbGeAlD
Nabumetone—PTGS2—tendon—systemic scleroderma	0.000598	0.0131	CbGeAlD
Nabumetone—PTGS1—lung—systemic scleroderma	0.000549	0.012	CbGeAlD
Nabumetone—PTGS2—lung—systemic scleroderma	0.000524	0.0115	CbGeAlD
Nabumetone—Anxiety—Lisinopril—systemic scleroderma	0.000204	0.00103	CcSEcCtD
Nabumetone—Dyspnoea—Leflunomide—systemic scleroderma	0.000203	0.00103	CcSEcCtD
Nabumetone—Discomfort—Lisinopril—systemic scleroderma	0.000202	0.00102	CcSEcCtD
Nabumetone—Dyspepsia—Leflunomide—systemic scleroderma	0.000201	0.00102	CcSEcCtD
Nabumetone—Pancreatitis—Prednisone—systemic scleroderma	0.0002	0.00102	CcSEcCtD
Nabumetone—Vomiting—Mometasone—systemic scleroderma	0.0002	0.00102	CcSEcCtD
Nabumetone—Dry mouth—Lisinopril—systemic scleroderma	0.0002	0.00101	CcSEcCtD
Nabumetone—Sweating increased—Prednisone—systemic scleroderma	0.000199	0.00101	CcSEcCtD
Nabumetone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000199	0.00101	CcSEcCtD
Nabumetone—Rash—Mometasone—systemic scleroderma	0.000198	0.00101	CcSEcCtD
Nabumetone—Asthenia—Captopril—systemic scleroderma	0.000198	0.00101	CcSEcCtD
Nabumetone—Dermatitis—Mometasone—systemic scleroderma	0.000198	0.00101	CcSEcCtD
Nabumetone—Decreased appetite—Leflunomide—systemic scleroderma	0.000198	0.00101	CcSEcCtD
Nabumetone—Confusional state—Lisinopril—systemic scleroderma	0.000197	0.001	CcSEcCtD
Nabumetone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000197	0.001	CcSEcCtD
Nabumetone—Headache—Mometasone—systemic scleroderma	0.000197	0.001	CcSEcCtD
Nabumetone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000197	0.001	CcSEcCtD
Nabumetone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000197	0.000999	CcSEcCtD
Nabumetone—Fatigue—Leflunomide—systemic scleroderma	0.000196	0.000998	CcSEcCtD
Nabumetone—Oedema—Lisinopril—systemic scleroderma	0.000196	0.000994	CcSEcCtD
Nabumetone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000196	0.000994	CcSEcCtD
Nabumetone—Pruritus—Captopril—systemic scleroderma	0.000196	0.000993	CcSEcCtD
Nabumetone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000195	0.000991	CcSEcCtD
Nabumetone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000991	CcSEcCtD
Nabumetone—Constipation—Leflunomide—systemic scleroderma	0.000195	0.00099	CcSEcCtD
Nabumetone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000987	CcSEcCtD
Nabumetone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000194	0.000984	CcSEcCtD
Nabumetone—Somnolence—Mycophenolic acid—systemic scleroderma	0.000193	0.000982	CcSEcCtD
Nabumetone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000981	CcSEcCtD
Nabumetone—Shock—Lisinopril—systemic scleroderma	0.000193	0.000978	CcSEcCtD
Nabumetone—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000976	CcSEcCtD
Nabumetone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000192	0.000974	CcSEcCtD
Nabumetone—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000191	0.000972	CcSEcCtD
Nabumetone—Abdominal pain—Azathioprine—systemic scleroderma	0.000191	0.000969	CcSEcCtD
Nabumetone—Body temperature increased—Azathioprine—systemic scleroderma	0.000191	0.000969	CcSEcCtD
Nabumetone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000963	CcSEcCtD
Nabumetone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000189	0.000961	CcSEcCtD
Nabumetone—Diarrhoea—Captopril—systemic scleroderma	0.000189	0.000961	CcSEcCtD
Nabumetone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000189	0.00096	CcSEcCtD
Nabumetone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000959	CcSEcCtD
Nabumetone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000957	CcSEcCtD
Nabumetone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000188	0.000957	CcSEcCtD
Nabumetone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000956	CcSEcCtD
Nabumetone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000188	0.000954	CcSEcCtD
Nabumetone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000187	0.000952	CcSEcCtD
Nabumetone—Nausea—Mometasone—systemic scleroderma	0.000187	0.00095	CcSEcCtD
Nabumetone—Anorexia—Lisinopril—systemic scleroderma	0.000187	0.000948	CcSEcCtD
Nabumetone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000186	0.000946	CcSEcCtD
Nabumetone—Weight increased—Prednisone—systemic scleroderma	0.000186	0.000945	CcSEcCtD
Nabumetone—Constipation—Mycophenolic acid—systemic scleroderma	0.000186	0.000944	CcSEcCtD
Nabumetone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000943	CcSEcCtD
Nabumetone—Weight decreased—Prednisone—systemic scleroderma	0.000185	0.00094	CcSEcCtD
Nabumetone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000938	CcSEcCtD
Nabumetone—Hyperglycaemia—Prednisone—systemic scleroderma	0.000184	0.000937	CcSEcCtD
Nabumetone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000932	CcSEcCtD
Nabumetone—Dizziness—Captopril—systemic scleroderma	0.000183	0.000929	CcSEcCtD
Nabumetone—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000183	0.000927	CcSEcCtD
Nabumetone—Depression—Prednisone—systemic scleroderma	0.000182	0.000923	CcSEcCtD
Nabumetone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000922	CcSEcCtD
Nabumetone—Urticaria—Leflunomide—systemic scleroderma	0.000181	0.000919	CcSEcCtD
Nabumetone—Abdominal pain—Leflunomide—systemic scleroderma	0.00018	0.000915	CcSEcCtD
Nabumetone—Body temperature increased—Leflunomide—systemic scleroderma	0.00018	0.000915	CcSEcCtD
Nabumetone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00018	0.000913	CcSEcCtD
Nabumetone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000179	0.00091	CcSEcCtD
Nabumetone—Myocardial infarction—Prednisone—systemic scleroderma	0.000179	0.000908	CcSEcCtD
Nabumetone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000906	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000178	0.000904	CcSEcCtD
Nabumetone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000178	0.000903	CcSEcCtD
Nabumetone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000178	0.000903	CcSEcCtD
Nabumetone—Insomnia—Lisinopril—systemic scleroderma	0.000177	0.000899	CcSEcCtD
Nabumetone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000898	CcSEcCtD
Nabumetone—Paraesthesia—Lisinopril—systemic scleroderma	0.000176	0.000893	CcSEcCtD
Nabumetone—Vomiting—Captopril—systemic scleroderma	0.000176	0.000893	CcSEcCtD
Nabumetone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000889	CcSEcCtD
Nabumetone—Dyspnoea—Lisinopril—systemic scleroderma	0.000175	0.000887	CcSEcCtD
Nabumetone—Rash—Captopril—systemic scleroderma	0.000174	0.000885	CcSEcCtD
Nabumetone—Dermatitis—Captopril—systemic scleroderma	0.000174	0.000885	CcSEcCtD
Nabumetone—Somnolence—Lisinopril—systemic scleroderma	0.000174	0.000884	CcSEcCtD
Nabumetone—Headache—Captopril—systemic scleroderma	0.000173	0.00088	CcSEcCtD
Nabumetone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000879	CcSEcCtD
Nabumetone—Dyspepsia—Lisinopril—systemic scleroderma	0.000172	0.000875	CcSEcCtD
Nabumetone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000172	0.000873	CcSEcCtD
Nabumetone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000172	0.000873	CcSEcCtD
Nabumetone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000871	CcSEcCtD
Nabumetone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000871	CcSEcCtD
Nabumetone—Asthma—Methotrexate—systemic scleroderma	0.000171	0.000868	CcSEcCtD
Nabumetone—Decreased appetite—Lisinopril—systemic scleroderma	0.00017	0.000864	CcSEcCtD
Nabumetone—Fatigue—Lisinopril—systemic scleroderma	0.000169	0.000857	CcSEcCtD
Nabumetone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000857	CcSEcCtD
Nabumetone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000853	CcSEcCtD
Nabumetone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000168	0.000853	CcSEcCtD
Nabumetone—Pancreatitis—Methotrexate—systemic scleroderma	0.000168	0.000851	CcSEcCtD
Nabumetone—Constipation—Lisinopril—systemic scleroderma	0.000167	0.00085	CcSEcCtD
Nabumetone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000842	CcSEcCtD
Nabumetone—Diarrhoea—Azathioprine—systemic scleroderma	0.000165	0.000839	CcSEcCtD
Nabumetone—Haemoglobin—Prednisone—systemic scleroderma	0.000164	0.000836	CcSEcCtD
Nabumetone—Nausea—Captopril—systemic scleroderma	0.000164	0.000834	CcSEcCtD
Nabumetone—Haemorrhage—Prednisone—systemic scleroderma	0.000164	0.000831	CcSEcCtD
Nabumetone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000831	CcSEcCtD
Nabumetone—Asthenia—Leflunomide—systemic scleroderma	0.000163	0.00083	CcSEcCtD
Nabumetone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000161	0.000819	CcSEcCtD
Nabumetone—Pruritus—Leflunomide—systemic scleroderma	0.000161	0.000819	CcSEcCtD
Nabumetone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00016	0.000813	CcSEcCtD
Nabumetone—Dysuria—Methotrexate—systemic scleroderma	0.00016	0.000812	CcSEcCtD
Nabumetone—Dizziness—Azathioprine—systemic scleroderma	0.00016	0.00081	CcSEcCtD
Nabumetone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000157	0.000799	CcSEcCtD
Nabumetone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000156	0.000792	CcSEcCtD
Nabumetone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000156	0.000792	CcSEcCtD
Nabumetone—Diarrhoea—Leflunomide—systemic scleroderma	0.000156	0.000792	CcSEcCtD
Nabumetone—Urticaria—Lisinopril—systemic scleroderma	0.000156	0.00079	CcSEcCtD
Nabumetone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000788	CcSEcCtD
Nabumetone—Abdominal pain—Lisinopril—systemic scleroderma	0.000155	0.000786	CcSEcCtD
Nabumetone—Body temperature increased—Lisinopril—systemic scleroderma	0.000155	0.000786	CcSEcCtD
Nabumetone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000782	CcSEcCtD
Nabumetone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000154	0.000781	CcSEcCtD
Nabumetone—Vomiting—Azathioprine—systemic scleroderma	0.000153	0.000779	CcSEcCtD
Nabumetone—Pneumonia—Methotrexate—systemic scleroderma	0.000153	0.000778	CcSEcCtD
Nabumetone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000777	CcSEcCtD
Nabumetone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000775	CcSEcCtD
Nabumetone—Rash—Azathioprine—systemic scleroderma	0.000152	0.000773	CcSEcCtD
Nabumetone—Dermatitis—Azathioprine—systemic scleroderma	0.000152	0.000772	CcSEcCtD
Nabumetone—Depression—Methotrexate—systemic scleroderma	0.000152	0.000772	CcSEcCtD
Nabumetone—Headache—Azathioprine—systemic scleroderma	0.000151	0.000768	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000151	0.000767	CcSEcCtD
Nabumetone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000767	CcSEcCtD
Nabumetone—Dizziness—Leflunomide—systemic scleroderma	0.000151	0.000765	CcSEcCtD
Nabumetone—Renal failure—Methotrexate—systemic scleroderma	0.00015	0.000761	CcSEcCtD
Nabumetone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000757	CcSEcCtD
Nabumetone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000149	0.000755	CcSEcCtD
Nabumetone—Stomatitis—Methotrexate—systemic scleroderma	0.000149	0.000754	CcSEcCtD
Nabumetone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000745	CcSEcCtD
Nabumetone—Arrhythmia—Prednisone—systemic scleroderma	0.000146	0.000743	CcSEcCtD
Nabumetone—Haematuria—Methotrexate—systemic scleroderma	0.000145	0.000738	CcSEcCtD
Nabumetone—Vomiting—Leflunomide—systemic scleroderma	0.000145	0.000736	CcSEcCtD
Nabumetone—Alopecia—Prednisone—systemic scleroderma	0.000145	0.000735	CcSEcCtD
Nabumetone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000144	0.000733	CcSEcCtD
Nabumetone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000144	0.00073	CcSEcCtD
Nabumetone—Rash—Leflunomide—systemic scleroderma	0.000144	0.00073	CcSEcCtD
Nabumetone—Dermatitis—Leflunomide—systemic scleroderma	0.000144	0.000729	CcSEcCtD
Nabumetone—Nausea—Azathioprine—systemic scleroderma	0.000143	0.000728	CcSEcCtD
Nabumetone—Headache—Leflunomide—systemic scleroderma	0.000143	0.000725	CcSEcCtD
Nabumetone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000142	0.000722	CcSEcCtD
Nabumetone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000718	CcSEcCtD
Nabumetone—Asthenia—Lisinopril—systemic scleroderma	0.00014	0.000713	CcSEcCtD
Nabumetone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000712	CcSEcCtD
Nabumetone—Pruritus—Lisinopril—systemic scleroderma	0.000139	0.000704	CcSEcCtD
Nabumetone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000138	0.000702	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—systemic scleroderma	0.000137	0.000698	CcSEcCtD
Nabumetone—Rash—Mycophenolic acid—systemic scleroderma	0.000137	0.000696	CcSEcCtD
Nabumetone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000137	0.000695	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—systemic scleroderma	0.000137	0.000695	CcSEcCtD
Nabumetone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000692	CcSEcCtD
Nabumetone—Headache—Mycophenolic acid—systemic scleroderma	0.000136	0.000692	CcSEcCtD
Nabumetone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000689	CcSEcCtD
Nabumetone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000689	CcSEcCtD
Nabumetone—Nausea—Leflunomide—systemic scleroderma	0.000135	0.000687	CcSEcCtD
Nabumetone—Diarrhoea—Lisinopril—systemic scleroderma	0.000134	0.00068	CcSEcCtD
Nabumetone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000132	0.000671	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—systemic scleroderma	0.000132	0.00067	CcSEcCtD
Nabumetone—Anaemia—Prednisone—systemic scleroderma	0.000132	0.000669	CcSEcCtD
Nabumetone—Agitation—Prednisone—systemic scleroderma	0.000131	0.000665	CcSEcCtD
Nabumetone—Angioedema—Prednisone—systemic scleroderma	0.00013	0.000661	CcSEcCtD
Nabumetone—Dizziness—Lisinopril—systemic scleroderma	0.000129	0.000658	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000129	0.000657	CcSEcCtD
Nabumetone—Nausea—Mycophenolic acid—systemic scleroderma	0.000129	0.000656	CcSEcCtD
Nabumetone—Malaise—Prednisone—systemic scleroderma	0.000128	0.000653	CcSEcCtD
Nabumetone—Vertigo—Prednisone—systemic scleroderma	0.000128	0.00065	CcSEcCtD
Nabumetone—Syncope—Prednisone—systemic scleroderma	0.000128	0.000649	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—systemic scleroderma	0.000128	0.000648	CcSEcCtD
Nabumetone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000642	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisone—systemic scleroderma	0.000125	0.000636	CcSEcCtD
Nabumetone—Vomiting—Lisinopril—systemic scleroderma	0.000124	0.000632	CcSEcCtD
Nabumetone—Rash—Lisinopril—systemic scleroderma	0.000123	0.000627	CcSEcCtD
Nabumetone—Dermatitis—Lisinopril—systemic scleroderma	0.000123	0.000626	CcSEcCtD
Nabumetone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000625	CcSEcCtD
Nabumetone—Hypertension—Prednisone—systemic scleroderma	0.000123	0.000625	CcSEcCtD
Nabumetone—Chills—Methotrexate—systemic scleroderma	0.000123	0.000623	CcSEcCtD
Nabumetone—Headache—Lisinopril—systemic scleroderma	0.000123	0.000623	CcSEcCtD
Nabumetone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000616	CcSEcCtD
Nabumetone—Anxiety—Prednisone—systemic scleroderma	0.000121	0.000614	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—systemic scleroderma	0.000121	0.000614	CcSEcCtD
Nabumetone—Discomfort—Prednisone—systemic scleroderma	0.00012	0.000609	CcSEcCtD
Nabumetone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000596	CcSEcCtD
Nabumetone—Nausea—Lisinopril—systemic scleroderma	0.000116	0.000591	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000116	0.000591	CcSEcCtD
Nabumetone—Oedema—Prednisone—systemic scleroderma	0.000116	0.000591	CcSEcCtD
Nabumetone—Shock—Prednisone—systemic scleroderma	0.000114	0.000581	CcSEcCtD
Nabumetone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000576	CcSEcCtD
Nabumetone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000112	0.000571	CcSEcCtD
Nabumetone—Anorexia—Prednisone—systemic scleroderma	0.000111	0.000563	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00011	0.000561	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—systemic scleroderma	0.00011	0.000559	CcSEcCtD
Nabumetone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000554	CcSEcCtD
Nabumetone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000549	CcSEcCtD
Nabumetone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000549	CcSEcCtD
Nabumetone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000546	CcSEcCtD
Nabumetone—Malaise—Methotrexate—systemic scleroderma	0.000107	0.000545	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—systemic scleroderma	0.000107	0.000543	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—systemic scleroderma	0.000107	0.000541	CcSEcCtD
Nabumetone—Insomnia—Prednisone—systemic scleroderma	0.000105	0.000534	CcSEcCtD
Nabumetone—Paraesthesia—Prednisone—systemic scleroderma	0.000104	0.00053	CcSEcCtD
Nabumetone—Cough—Methotrexate—systemic scleroderma	0.000104	0.000528	CcSEcCtD
Nabumetone—Dyspepsia—Prednisone—systemic scleroderma	0.000102	0.00052	CcSEcCtD
Nabumetone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000518	CcSEcCtD
Nabumetone—Decreased appetite—Prednisone—systemic scleroderma	0.000101	0.000513	CcSEcCtD
Nabumetone—Fatigue—Prednisone—systemic scleroderma	0.0001	0.000509	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—systemic scleroderma	0.0001	0.000509	CcSEcCtD
Nabumetone—Constipation—Prednisone—systemic scleroderma	9.94e-05	0.000505	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—systemic scleroderma	9.8e-05	0.000498	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—systemic scleroderma	9.72e-05	0.000494	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisone—systemic scleroderma	9.58e-05	0.000487	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—systemic scleroderma	9.51e-05	0.000483	CcSEcCtD
Nabumetone—Gastrointestinal pain—Prednisone—systemic scleroderma	9.51e-05	0.000483	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—systemic scleroderma	9.39e-05	0.000477	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—systemic scleroderma	9.26e-05	0.000471	CcSEcCtD
Nabumetone—Urticaria—Prednisone—systemic scleroderma	9.24e-05	0.000469	CcSEcCtD
Nabumetone—Abdominal pain—Prednisone—systemic scleroderma	9.19e-05	0.000467	CcSEcCtD
Nabumetone—Body temperature increased—Prednisone—systemic scleroderma	9.19e-05	0.000467	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—systemic scleroderma	8.79e-05	0.000446	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—systemic scleroderma	8.73e-05	0.000443	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—systemic scleroderma	8.66e-05	0.00044	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—systemic scleroderma	8.64e-05	0.000439	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisone—systemic scleroderma	8.57e-05	0.000435	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—systemic scleroderma	8.55e-05	0.000434	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—systemic scleroderma	8.45e-05	0.000429	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—systemic scleroderma	8.38e-05	0.000426	CcSEcCtD
Nabumetone—Asthenia—Prednisone—systemic scleroderma	8.34e-05	0.000424	CcSEcCtD
Nabumetone—Pruritus—Prednisone—systemic scleroderma	8.23e-05	0.000418	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—systemic scleroderma	8.01e-05	0.000407	CcSEcCtD
Nabumetone—Diarrhoea—Prednisone—systemic scleroderma	7.96e-05	0.000404	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.95e-05	0.000404	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—systemic scleroderma	7.72e-05	0.000392	CcSEcCtD
Nabumetone—Dizziness—Prednisone—systemic scleroderma	7.69e-05	0.000391	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—systemic scleroderma	7.68e-05	0.00039	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—systemic scleroderma	7.68e-05	0.00039	CcSEcCtD
Nabumetone—Vomiting—Prednisone—systemic scleroderma	7.39e-05	0.000376	CcSEcCtD
Nabumetone—Rash—Prednisone—systemic scleroderma	7.33e-05	0.000372	CcSEcCtD
Nabumetone—Dermatitis—Prednisone—systemic scleroderma	7.32e-05	0.000372	CcSEcCtD
Nabumetone—Headache—Prednisone—systemic scleroderma	7.28e-05	0.00037	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—systemic scleroderma	7.16e-05	0.000364	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—systemic scleroderma	6.97e-05	0.000354	CcSEcCtD
Nabumetone—Nausea—Prednisone—systemic scleroderma	6.91e-05	0.000351	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—systemic scleroderma	6.87e-05	0.000349	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—systemic scleroderma	6.65e-05	0.000338	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—systemic scleroderma	6.43e-05	0.000326	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—systemic scleroderma	6.18e-05	0.000314	CcSEcCtD
Nabumetone—Rash—Methotrexate—systemic scleroderma	6.13e-05	0.000311	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—systemic scleroderma	6.12e-05	0.000311	CcSEcCtD
Nabumetone—Headache—Methotrexate—systemic scleroderma	6.09e-05	0.000309	CcSEcCtD
Nabumetone—Nausea—Methotrexate—systemic scleroderma	5.77e-05	0.000293	CcSEcCtD
